Signaturefd, LLC Intellia Therapeutics, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 308 shares of NTLA stock, worth $2,926. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308

Previous 471 34.61%

Holding current value

$2,926

Previous $10,000 40.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$19.72 - $27.36 $3,214 - $4,459	-163 Reduced 34.61%	308 $6,000
Q2 2024 Jul 29, 2024	SELL	$20.02 - $27.22 $7,887 - $10,724	-394 Reduced 45.55%	471 $10,000
Q1 2024 May 03, 2024	SELL	$23.82 - $32.8 $17,317 - $23,845	-727 Reduced 45.67%	865 $23,000
Q4 2023 Jan 31, 2024	BUY	$23.16 - $32.34 $17,393 - $24,287	751 Added 89.3%	1,592 $48,000
Q3 2023 Nov 03, 2023	BUY	$31.62 - $45.78 $4,205 - $6,088	133 Added 18.79%	841 $26,000
Q2 2023 Aug 01, 2023	SELL	$34.58 - $46.03 $2,904 - $3,866	-84 Reduced 10.61%	708 $28,000
Q1 2023 Apr 28, 2023	BUY	$33.3 - $44.82 $15,784 - $21,244	474 Added 149.06%	792 $29,000
Q4 2022 Jan 27, 2023	BUY	$33.21 - $62.69 $99 - $188	3 Added 0.95%	318 $11,000
Q3 2022 Nov 08, 2022	BUY	$53.92 - $71.7 $1,401 - $1,864	26 Added 9.0%	315 $18,000
Q2 2022 Aug 10, 2022	BUY	$38.49 - $76.21 $1,154 - $2,286	30 Added 11.58%	289 $15,000
Q1 2022 May 02, 2022	SELL	$58.27 - $118.99 $1,515 - $3,093	-26 Reduced 9.12%	259 $19,000
Q4 2021 Jan 25, 2022	BUY	$100.76 - $138.36 $1,309 - $1,798	13 Added 4.78%	285 $34,000
Q3 2021 Oct 28, 2021	SELL	$132.37 - $176.78 $5,691 - $7,601	-43 Reduced 13.65%	272 $36,000
Q2 2021 Jul 26, 2021	SELL	$60.88 - $161.91 $2,130 - $5,666	-35 Reduced 10.0%	315 $51,000
Q1 2021 Apr 30, 2021	BUY	$46.59 - $83.68 $4,659 - $8,368	100 Added 40.0%	350 $28,000
Q4 2020 Feb 11, 2021	BUY	$18.83 - $63.53 $1,675 - $5,654	89 Added 55.28%	250 $14,000
Q3 2020 Nov 03, 2020	BUY	$17.47 - $24.93 $1,065 - $1,520	61 Added 61.0%	161 $3,000
Q2 2020 Jul 30, 2020	SELL	$11.14 - $22.87 $3,698 - $7,592	-332 Reduced 76.85%	100 $2,000
Q1 2020 Apr 23, 2020	BUY	$9.44 - $15.58 $3,105 - $5,125	329 Added 319.42%	432 $5,000
Q1 2019 May 09, 2019	BUY	$12.79 - $17.62 $38 - $52	3 Added 3.0%	103 $2,000
Q3 2018 Nov 15, 2018	SELL	$25.78 - $32.6 $11,601 - $14,670	-450 Reduced 81.82%	100 $3,000
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $2,002 - $3,079	100 Added 22.22%	550 $15,000
Q1 2018 May 08, 2018	BUY	$19.43 - $34.95 $8,743 - $15,727	450 New	450 $9,000

Others Institutions Holding NTLA

# of Institutions

316

Shares Held

91.7M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $722M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account